Organogenesis Holdings (ORGO) Total Debt (2017 - 2024)
Organogenesis Holdings (ORGO) posted quarterly Total Debt of $62.1 million for Q3 2024, down 8.11% year-over-year from $67.6 million in Q4 2023, and down 2.16% quarter-over-quarter from $63.5 million in Q2 2024.
Organogenesis Holdings (ORGO) Total Debt (2017 - 2024) Analysis & Trends
Organogenesis Holdings' Total Debt history runs 8 years deep, the most recent figure standing at $62.1 million for Q3 2024.
- In Q3 2024, Total Debt fell 8.11% year-over-year to $62.1 million; the TTM figure through Sep 2024 stood at $62.1 million (down 8.11% YoY), while the FY2023 annual figure was $66.2 million, down 6.41% from the prior year.
- Total Debt for Q3 2024 stood at $62.1 million, down from $63.5 million in the prior quarter.
- The five-year high for Total Debt was $92.5 million in Q2 2021, with the low at $11.7 million in Q1 2020.
- The 5-year median for Total Debt is $67.6 million (2023), against an average of $64.4 million.
- The sharpest annual moves came in 2020 and 2021: Total Debt plunged 74.07% in 2020, then surged 412.14% in 2021.
- Organogenesis Holdings' Total Debt stood at $59.7 million in 2020, then increased by 22.97% to $73.4 million in 2021, then retreated by 3.62% to $70.8 million in 2022, then declined by 6.41% to $66.2 million in 2023, then decreased by 6.21% to $62.1 million in 2024.
- Business Quant data shows ORGO's Total Debt at $62.1 million in Q3 2024, $63.5 million in Q2 2024, and $64.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 62.12 Mn |
| Jun 30, 2024 | 63.49 Mn |
| Mar 31, 2024 | 64.86 Mn |
| Dec 31, 2023 | 66.23 Mn |
| Sep 30, 2023 | 67.60 Mn |
| Jun 30, 2023 | 68.97 Mn |
| Mar 31, 2023 | 69.87 Mn |
| Dec 31, 2022 | 70.77 Mn |
| Sep 30, 2022 | 72.60 Mn |
| Jun 30, 2022 | 72.57 Mn |
| Mar 31, 2022 | 73.00 Mn |
| Dec 31, 2021 | 73.43 Mn |
| Sep 30, 2021 | 76.72 Mn |
| Jun 30, 2021 | 92.50 Mn |
| Mar 31, 2021 | 59.75 Mn |
| Dec 31, 2020 | 59.71 Mn |
| Sep 30, 2020 | 51.02 Mn |
| Jun 30, 2020 | 46.02 Mn |
| Mar 31, 2020 | 11.67 Mn |
| Dec 31, 2019 | 38.48 Mn |